MARC A. COHEN
Marc A. Cohen is the Executive Chairman of Frequency Therapeutics. He is also a Co-founder and Executive Chairman of C4 Therapeutics. Additionally, Mr. Cohen is the Co-founder and Chief Executive Officer of Bublup, Inc.; Neuro Tennis, Inc.; and COBRO Ventures, Inc.; as well as the Co-founder and Chairman of Acetylon Pharmaceuticals, Inc. and OncoPep, Inc., two biotech companies spun out of Dana-Farber Cancer Institute and Harvard University. He was the Chief Executive Officer, Chairman and Co-founder of OPNET Technologies, Inc., a world leader in network and application performance management. OPNET was sold to Riverbed Technology in December 2012. He is currently a Trustee of the Dana-Farber Cancer Institute where he is focusing on accelerating translational research and increasing the flow of new therapies to patients. Mr. Cohen received a B.S. in Engineering from Harvard University and an M.S. in Electrical Engineering from Stanford University.